Progressive sclerosing cholangitis after septic shock: A new variant of vanishing bile duct disorders

Gut

Volumn 52, Issue 5, 2003, Pages 688-693

  Engler, S ^a,b   Elsing, C ^b   Flechtenmacher, C ^b   Theilmann, L ^b   Stremmel, W ^b   Stiehl, A ^b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT DISEASE; BRAIN ISCHEMIA; CELL PROLIFERATION; CHOLESTASIS; CLINICAL ARTICLE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; FOLLOW UP; GENETIC VARIABILITY; HUMAN; INTENSIVE CARE UNIT; LIVER BIOPSY; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; SCLEROSING CHOLANGITIS; SEPTIC SHOCK;

ADOLESCENT; AGED; BILE DUCTS; BIOPSY; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGITIS, SCLEROSING; CONSTRICTION, PATHOLOGIC; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; SHOCK, SEPTIC; TREATMENT OUTCOME;

EID: 0038300080     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.5.688     Document Type: Article

References (29)

1. Desmet VJ. Vanishing bile duct disorders. In: Boyer JL, Ockner RK, eds. Progress in Liver Diseases, vol X. Philadelphia: WB Saunders; 1992:89-121.
2. Desmet VJ, van Eyken P, Roskams T. Histopathology of vanishing bile duct diseases. Adv Clin Path 1998;2:87-99.
3. Amor A, Chapoutot C, Michel J, et al. Secondary sclerosing cholangitis. Presse Med 1995;24:948-52.
4. Loinaz C, Gonzalez EM, Jimenez C, et al. Long-term biliary complications after liver surgery leading to liver transplantation. World J Surg 2001;25:1260-3.
5. Schmitt M, Kölbel CB, Müller MK, et al. Sklerosierende Cholangitis nach Verbrennung. Z Gastroenterol 1997;35:929-34.
6. Scheppach W, Druge G, Wittenberg G, et al. Sclerosing cholangitis and liver cirrhosis after extrabiliary infections: report on three cases. Crit Care Med 2001;29:438-41.
7. Sebagh M, Farges O, Kalil A, et al. Sclerosing cholangitis following human orthotopic liver transplantation. Am J Surg Pathol 1995;19:81-90.
8. Tsimoyiannis EC, Grantzis E, Moutesidou K, et al. Secondary sclerosing cholangitis: after injection of formaldehyde into a hyatid cyst in the liver. Eur J Surg 1995;161:299-300.
9. Heneghan MA, Sylvestre PB. Cholestatic diseases of liver transplantation. Semin Gastrointest Dis 2001;12:133-47.
10. Quigley E, Marsh M, Shaffer J, et al. Hepatobiliary complications of total parenteral nutrition. Gastroenterology 1993;104:286-301.
11. Müller M. Hepatische Komplikationen bei parenteraler Ernährung. Z Gastroenterol 1996;34:36-40.
12. Baker F, Rosenberg W. Hepatic complications of total parenteral nutrition. Am J Med 1987;82:489-97.
13. Machnik G. Histologische Veränderungen des Lebergewebes bei Cholestase. Z Gastroenterol 1993;31(suppl 2):7-10.
14. Holzbach R. Gallbladderstasis: consequence of long-term parenteral hyperalimentation and risk factor for cholelithiasis. Gastroenterology 1983;84:1055-8.
15. Messing B, Bories C, Kunstlinger F, et al. Does total parenteral nutrition induce gallbladder sludge formation and lithiasis? Gastroenterology 1983;84:1012-19.
16. DeBoer SY, Masdee AAM, Jebbing MCW. Effect of intravenous fat on cholecystokinin secretian and gallbladder motility in man. JPEN J Parenter Enteral Nutr 1992;16:16-19.
17. Pitt H, King I, Mann L. Increased risk of cholelithiasis with prolonged total parenteral nutrition. Am J Surg 1983;145:106-11.
18. Brophy C. Gastrointestinal vascular ischemic syndromes. Curr Opin Gen Surg 1993;225-31.
19. McCarthy Pastores S, Katz D, Kvetan V. Splanchnic ischemia and gut mucosal injury in sepsis and the multiple organ dysfunction syndrome. Am J Gastroenterol 1996;91:1697-710.
20. Cicalese L, Caraceni P, Nalesnik M, et al. Oxygen free radical content and neutrophil infiltration are important determinants in mucosal injury after rat small bowel transplantation. Transplantation 1996;62:161-6.
21. Moore F, Moore E. Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin North Am 1995;75:257-77.
22. Deitch EA. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch Surg 1990;125:403-8.
23. Baron P, Traber LD, Traber DL, et al. Gut failure and translocation following burn and sepsis. J Surg Res 1994;57:197-204.
24. Tadros T, Traber DL, Herndon DN. Hepatic blood flow and oxygen consumption after burn and sepsis. J Trauma 2000;49:101-8.
25. Lee J, Schutz S, England R, et al. Endoscopic therapy of sclerosing cholangitis. Hepatology 1995;21:661-7.
26. Wagner S, Gebel M, Trautwein C, et al. Endoscopic management of biliary tract strictures in primary sclerosing cholangitis. Endoscopy 1996;28:546-51.
27. Baluyut AR, Sherman S, Lehman GA, et al. Impact of endoscopic therapy on the survival of patients with primary sderosing cholangitis. Gastrointest Endosc 2001;53:308-12.
28. Stiehl A, Rudolph G, Sauer P, et al. Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. J Hepatol 1997;26:560-6.
29. Stiehl A, Rudolph G, Klöters-Plachky P, et al. Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome of endoscopic treatment. J Hepatol 2002;36:151-6.